Centers Lab NJ LLC

Centers Lab NJ LLC was paid $27.84M by Medicaid between May 2020 and Dec 2024, across 259 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 50% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#14 of 122

Median peer was paid$1.29M

This provider vs. median22×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	27,117	$717K
2021	377,590	$8.15M
2022	895,466	$11.74M
2023	887,621	$5.44M
2024incomplete	447,038	$1.80M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	50%	249,341	165,230	$13.87M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	15%	224,972	150,983	$4.16M
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	3.2%	89,526	79,563	$892K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.0%	11,199	9,503	$826K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.7%	25,186	19,453	$748K
87631		2.3%	16,008	14,757	$649K
80053	Comprehensive metabolic panel	2.3%	145,776	113,567	$643K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.6%	39,521	35,623	$442K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	198,283	138,969	$334K
86769		<1%	9,153	8,601	$276K
83021		<1%	30,016	26,466	$241K
84443	Thyroid stimulating hormone (TSH)	<1%	66,095	59,748	$227K

247 more codes

80048	Basic metabolic panel (calcium, ionized)	<1%	54,575	$211K
83036	Hemoglobin; glycosylated (A1C)	<1%	46,993	$199K
87486		<1%	19,908	$185K
80050	General health panel	<1%	11,098	$181K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	217,517	$180K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	10,346	$178K
80061	Lipid panel	<1%	75,410	$176K
87581		<1%	19,914	$155K
82607		<1%	32,128	$144K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	12,055	$114K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	36,021	$112K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	210,068	$102K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	12,085	$95K
83880		<1%	5,737	$94K
87088		<1%	27,575	$92K
82746		<1%	26,113	$85K
86480		<1%	3,625	$80K
87086	Culture, bacterial; quantitative colony count, urine	<1%	27,845	$80K
84439		<1%	26,513	$78K
80164		<1%	14,223	$68K
87390		<1%	9,317	$66K
87536		<1%	1,231	$66K
82728		<1%	15,208	$64K
80177		<1%	8,753	$62K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,702	$61K
87186		<1%	19,788	$55K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	9,572	$52K
86803		<1%	11,655	$47K
84153		<1%	7,348	$46K
87481		<1%	4,480	$46K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	4,972	$45K
86696		<1%	7,686	$44K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	5,695	$43K
86702		<1%	9,394	$41K
87500		<1%	3,903	$40K
81001		<1%	38,858	$38K
80202		<1%	5,728	$37K
87340		<1%	10,666	$36K
87641		<1%	3,917	$35K
85610		<1%	17,251	$34K
86780		<1%	8,299	$32K
86701		<1%	9,391	$31K
84134		<1%	6,455	$30K
86140		<1%	13,243	$29K
83540		<1%	18,952	$29K
87077		<1%	7,285	$26K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	9,033	$24K
83550		<1%	15,208	$22K
83970		<1%	1,337	$21K
86695		<1%	7,014	$21K
84436		<1%	15,521	$20K
84403		<1%	2,822	$20K
84480		<1%	6,810	$19K
80076		<1%	6,997	$18K
87071		<1%	8,080	$17K
82140		<1%	2,584	$17K
87040		<1%	3,914	$15K
83735		<1%	12,707	$14K
85651		<1%	13,872	$14K
36415	Collection of venous blood by venipuncture	<1%	60,347	$14K
87522	Neg quan hep c or qual rna	<1%	773	$14K
84402		<1%	2,038	$13K
87493		<1%	1,064	$13K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	585	$12K
84481		<1%	3,303	$12K
86706		<1%	4,658	$11K
84100		<1%	10,982	$11K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,152	$11K
84550		<1%	9,229	$11K
82248		<1%	5,685	$11K
85730		<1%	4,319	$10K
80185		<1%	1,605	$10K
83615		<1%	5,800	$10K
86003		<1%	1,176	$9K
86618		<1%	1,751	$9K
86617		<1%	1,116	$9K
83090		<1%	1,578	$8K
87634		<1%	1,376	$8K
86665		<1%	949	$8K
85045		<1%	4,271	$8K
84146		<1%	1,449	$7K
86704		<1%	1,892	$7K
81513		<1%	347	$7K
86762		<1%	1,812	$7K
86361		<1%	640	$7K
83655		<1%	1,900	$6K
87081		<1%	3,172	$6K
83001		<1%	1,487	$6K
84145		<1%	724	$6K
83002		<1%	1,441	$6K
80178		<1%	3,034	$6K
82670		<1%	960	$6K
86708		<1%	1,521	$6K
87070		<1%	1,285	$6K
83516		<1%	861	$5K
85027		<1%	3,226	$5K
86141		<1%	1,851	$5K
82043		<1%	5,795	$5K
80159		<1%	638	$5K
87205		<1%	2,738	$5K
86709		<1%	2,008	$5K
86360		<1%	218	$5K
86765		<1%	1,092	$5K
84144		<1%	991	$5K
86747		<1%	664	$5K
86800		<1%	1,433	$4K
85379		<1%	864	$4K
82784		<1%	1,353	$4K
86328		<1%	168	$4K
82550		<1%	2,698	$4K
80162		<1%	784	$4K
86787		<1%	1,462	$4K
87147		<1%	3,659	$4K
84466		<1%	605	$4K
86592		<1%	4,119	$4K
87521	Neg quan hep c or qual rna	<1%	298	$4K
86376		<1%	1,304	$4K
82274		<1%	2,084	$4K
82977		<1%	4,077	$4K
84681		<1%	375	$4K
82378		<1%	468	$4K
86738		<1%	496	$3K
80156		<1%	632	$3K
87480		<1%	528	$3K
86735		<1%	993	$3K
86038		<1%	1,734	$3K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	631	$3K
87510		<1%	518	$3K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	39	$3K
87660		<1%	519	$3K
84702		<1%	1,639	$3K
87084		<1%	607	$3K
86215		<1%	770	$3K
86645		<1%	526	$3K
82533		<1%	617	$3K
80184		<1%	378	$3K
84478		<1%	1,806	$3K
86644		<1%	531	$3K
83690		<1%	1,105	$2K
82652		<1%	756	$2K
84445		<1%	307	$2K
86777		<1%	757	$2K
86778		<1%	726	$2K
82150		<1%	1,354	$2K
88141		<1%	497	$2K
87653		<1%	516	$2K
86431		<1%	1,372	$2K
82627		<1%	410	$2K
82465		<1%	2,028	$2K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	151	$2K
87625		<1%	645	$2K
86235		<1%	481	$2K
84479		<1%	8,417	$2K
82785		<1%	735	$2K
86060		<1%	823	$2K
82570		<1%	3,128	$2K
82947		<1%	1,051	$2K
84154		<1%	266	$2K
86256		<1%	444	$2K
86870		<1%	460	$2K
82668		<1%	381	$2K
86705		<1%	849	$2K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	1,281	$1K
83525		<1%	905	$1K
81243		<1%	538	$1K
85008		<1%	11,712	$1K
84132		<1%	652	$1K
86308		<1%	763	$1K
82105		<1%	775	$1K
83721		<1%	3,296	$1K
81401		<1%	510	$1K
84425		<1%	233	$1K
86364		<1%	215	$913.36
84207		<1%	143	$794.32
86225		<1%	337	$791.38
85660		<1%	1,050	$771.99
87507		<1%	34	$716.32
82040		<1%	652	$666.79
84703		<1%	521	$665.51
87529		<1%	26	$650.20
86900		<1%	1,251	$624.94
86901		<1%	1,251	$623.99
86258		<1%	186	$592.84
85004		<1%	239	$526.92
87506		<1%	52	$473.39
84156		<1%	530	$429.77
86301		<1%	179	$416.85
84484		<1%	122	$387.23
80069		<1%	97	$380.76
82950		<1%	516	$360.98
86255		<1%	52	$341.64
85007		<1%	6,621	$338.53
87799		<1%	79	$333.99
87512		<1%	79	$332.68
82542		<1%	122	$329.90
87045		<1%	93	$305.19
82397		<1%	50	$300.06
86664		<1%	68	$297.37
80175		<1%	47	$284.37
82310		<1%	258	$260.79
84450		<1%	726	$228.12
87449		<1%	69	$227.62
84630		<1%	116	$212.93
86663		<1%	54	$190.72
86160		<1%	127	$175.61
86039		<1%	49	$166.14
84460		<1%	320	$161.85
84165		<1%	92	$153.27
S9529	Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient	<1%	86	$151.20
86200		<1%	78	$146.94
87046		<1%	94	$141.29
82985		<1%	26	$138.06
84305		<1%	13	$127.56
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	33	$126.30
83010		<1%	43	$101.65
86850		<1%	70	$96.45
80183		<1%	12	$90.40
82672		<1%	20	$88.72
86304		<1%	52	$72.85
84155		<1%	222	$64.80
82180		<1%	51	$49.48
82330		<1%	12	$45.86
84597		<1%	46	$45.84
84590		<1%	50	$44.93
84446		<1%	46	$41.84
84252		<1%	35	$41.65
82525		<1%	37	$40.05
83921		<1%	36	$39.36
82565		<1%	28	$36.29
83883		<1%	14	$30.00
83718		<1%	144	$29.15
82247		<1%	77	$27.75
84255		<1%	20	$26.75
83018		<1%	16	$26.35
84591		<1%	35	$19.80
84520		<1%	28	$19.09
85018		<1%	110	$15.11
83785		<1%	15	$13.33
82300		<1%	16	$11.82
82495		<1%	15	$10.14
82175		<1%	19	$9.49
82380		<1%	33	$9.22
83825		<1%	17	$8.13
85014		<1%	14	$7.13
80349		0%	17	$0.00
83789		0%	20	$0.00
99080		0%	694	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHALBERSTAM, ASHER (MEDICAL BILLER)